top of page

Dactino 0.5 mg Injection

SKU Chandra Bhagat Pharma Pvt Ltd
原始價格

$5,66

促銷價格

$4,41

Dactino 0.5 mg Injection is an innovative antibiotic that plays a crucial role in oncology, effectively targeting various malignancies such as Ewing's sarcoma, Wilms' tumor, and childhood rhabdomyosarcoma, as well as skin cancer and testicular and uterine cancers in both adults and children. This medication operates by inhibiting the growth of cancer cells, thus slowing down disease progression and improving treatment outcomes. While Dactino offers promising results, it is essential to be aware of potential side effects, including allergic reactions and impacts on liver function, necessitating regular monitoring by healthcare providers. Patients should discuss their medical history and any ongoing medications with their doctor to mitigate risks. Dactino is typically administered through injection, allowing for controlled dosing and effective absorption. As with any cancer treatment, the benefits of Dactino should be weighed against its risks, ensuring a personalized approach to therapy. Overall, Dactino 0.5 mg Injection stands as a vital option in the fight against various cancers, contributing to enhanced patient care and management strategies.

數量

Active Pharmaceutical Ingredient

Dactinomycin 0.5 mg

Uses

• Dactino 0 5 mg injection is utilized in the treatment of Ewing’s sarcoma, a type of bone cancer that primarily affects children and young adults. This medication helps to inhibit the growth of cancer cells, contributing to better management of the disease. In clinical settings, Dactino 0 5 mg injection is often part of a comprehensive treatment plan tailored for patients diagnosed with this aggressive cancer. By targeting specific pathways, it aims to improve patient outcomes.
• Rhabdomyosarcoma, a cancer of the muscle tissue, can also be effectively treated with Dactino 0 5 mg injection. This drug works by interfering with the proliferation of malignant cells, thus aiding in the control of tumor growth. Healthcare professionals may recommend Dactino 0 5 mg injection as part of a multi-modal approach to therapy. Its role in treating this rare condition can be significant in enhancing the quality of life for affected individuals.
• In cases of melanoma, a serious form of skin cancer, Dactino 0 5 mg injection may be employed to manage the disease. This medication helps to slow down the spread of cancerous cells and can be used in conjunction with other treatments. Physicians may consider Dactino 0 5 mg injection for patients who require a targeted therapy option. Its effectiveness in this context underscores its importance in oncology.
• Dactino 0 5 mg injection is also indicated for treating Wilms’ tumor, a type of kidney cancer commonly seen in children. The injection assists in controlling tumor progression and is often used within a broader treatment regimen. Oncologists may choose Dactino 0 5 mg injection based on its ability to target specific cancer cells effectively. This approach can be crucial in managing pediatric oncology cases.

Benefits

Ewing’s sarcoma (bone cancer): Ewing's sarcoma is a rare type of cancer that primarily affects the bones or soft tissues. The most common symptom of Ewing's sarcoma is pain and swelling around the affected bone or soft tissue. Other symptoms may include a noticeable lump or mass, fever, fatigue, weight loss, and bone fractures. It usually affects children and young adults. Side effects of Dactino 0.5 mg Injection helps to treat Ewing’s sarcoma. It may be given alone or in combination with other medicines. It is a potent and very toxic medicine, and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated. Rhabdomyosarcoma (muscle cancer): Rhabdomyosarcoma is a type of cancer that arises from the soft tissues, specifically the skeletal muscle cells. It is the most common soft tissue sarcoma in children and adolescents, although it can also occur in adults. The symptoms of rhabdomyosarcoma vary depending on the location of the tumor. Common signs and symptoms may include a visible or palpable mass or swelling, pain or tenderness at the tumor site, and limited range of motion. It may be given alone or in combination with other medicines to remove the tumor, prevent its spread, and minimize the risk of recurrence. Melanoma (skin cancer): Melanoma is a type of skin cancer that develops from melanocytes, the cells that produce the pigment melanin. Melanoma can occur anywhere on the body, including areas not exposed to the sun. It is considered the most aggressive form of skin cancer because it has the potential to spread to other parts of the body if not detected and treated early. The most common sign of melanoma is a new or existing mole that undergoes changes in size, shape, color, or texture. Dactino 0.5 mg Injection is given only under medical guidance. Consult your doctor if you have any doubts. Wilms’ tumor (kidney cancer usually appears in children): Wilms' tumor, also known as nephroblastoma, is a type of kidney cancer that primarily affects children. It is the most common type of kidney cancer in children, typically occurring between the ages of 2 and 5 years old. The most common symptoms of Wilms' tumor may include a painless, palpable mass or swelling in the abdomen, usually on one side. Other possible signs and symptoms include abdominal pain, blood in the urine, high blood pressure, fever, and weight loss. Benefits of Dactino 0.5 mg Injection is used along with other medicines or treatment modalities such as surgery, radiation, or chemotherapy, depending on the stage or severity of the cancer and the condition of the patient. Follow the doctor’s instructions carefully to get the most benefit. Testicular cancer: Testicular cancer is a type of cancer that develops in the testicles, which are the male reproductive organs that produce sperm and testosterone. The most common symptom of testicular cancer is a painless lump or swelling in the testicles. Dactino 0.5 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells in men. It is given as an injection by a doctor or nurse and should not be self-administered. Uterine (Endometrial) Cancer: Uterine cancer, also known as endometrial cancer, affects the lining of the uterus (endometrium). It is the most common cancer of the female reproductive system and typically affects women after menopause. The most common symptom of uterine cancer is abnormal vaginal bleeding, particularly postmenopausal bleeding. Uses of Dactino 0.5 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells in women. It is given as an injection by a doctor or nurse and should not be self-administered.

Side Effects

Uses of Dactino 0.5 mg Injection adverse effects are based on different factors, and some of them are your medical history, immunity system, etc. Symptoms between two people will never be the same.

Most Common Side Effects

• Diarrhea
• Hair Loss
• Constipation
• Chest Pain
• Tingling in Feet and Feet
• Skin Rashes
• Damage of Soft Tissue

Common Side Effects

• Liver problems Severe Bleeding
• Tumor Lysis Syndrome

How To Use

Side effects of Dactino 0.5 mg Injection is given intravenously under the supervision of your doctor or a nurse in a hospital. Self-administration is not recommended to the patient.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Dactino 0.5 mg Injection. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Uses of Dactino 0.5 mg Injection may be safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Dactino 0.5 mg Injection may not be needed in these patients. Please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking How Dactino 0.5 mg Injection works. Dactino 0.5 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Dactino 0.5 mg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Benefits of Dactino 0.5 mg Injection is used with caution in patients with liver-related disease. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Uses of Dactino 0.5 mg Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Side effects of Dactino 0.5 mg Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: It is unknown whether driving while taking a Dactino 0.5 mg Injection alters driving ability. Do not drive if you experience any side effects.

bottom of page